• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597081)   Today's Articles (5279)   Subscriber (49345)
For: Gupta N, Hanley MJ, Sinha V. Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase-positive non-small cell lung cancer. Br J Clin Pharmacol 2022;88:3922-3923. [PMID: 35350085 DOI: 10.1111/bcp.15322] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Accepted: 02/28/2022] [Indexed: 01/26/2023]  Open
Number Cited by Other Article(s)
1
Koele SE, van Beek SW, van der Wekken AJ, Piet B, van den Heuvel MM, Ter Heine R. Pharmacokinetically guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients. Br J Clin Pharmacol 2022;88:3920-3921. [PMID: 35350084 DOI: 10.1111/bcp.15321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 03/15/2022] [Indexed: 11/29/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA